The in vitro DM1 models established thus successfully recapitulated two important DM1-related phenotypes, namely, nuclear MBNL1 aggregation and the downstream alternative splicing defects, as validated by newly established quantitative analyses. The gene discussed is MBNL1; the disease is myotonic dystrophy type 1.